2013 American Transplant Congress Archives - Page 101 of 178

Paired Donation (PD) Problem Solving 101-A Single Center Protocol to Rapidly Facilitate Large Simultaneous Swaps

L. Jaber, D. John, K. Ueda, W. Bry, S. Katznelson, V. Peddi
Paired Kidney Analysis of Delayed Graft Function: Recipient Risk Factors for and Role in Graft Survival, A

J. Malheiro, P. Aguiar, I. Fonseca, L. Martins, M. Almeida, S. Pedroso, L. Dias, A. Henriques, A. Cabrita
Pancreas (Px) Transplantation (Tx) Following Donation after Cardiac Death (DCD): 5 Year Outcomes – Matched Pair Analysis

N. Chandolias, J. Lohlun, D. Radosevich, E. Finger, T. Dunn, R. Kandaswamy
Pancreas Re-Transplantation Graft Survival Is Comparable to Primary Pancreas after Kidney Transplantation

J. Seal, M. Selzner, M. Marquez, F. Bazerbachi, I. McGilvray, J. Schiff, A. Norgate, M. Cattral
Pancreas Transplant Outcomes May Be Dependent on Center Experience

A. Kukla, S. Gustafson, B. Thompson, N. Salkowski, J. Snyder, R. Kandaswamy, A. Israni
Pancreas Transplantation: Personal Factors Associated with Good and Poor Post-Transplant Adaptive Response

P. Scott, A. Krause, G. Samiran, T. Taber, J. Fridell
Parent and Child Perceptions of Long Term Psychosocial Functioning at > 5 Years Post-Intestine Transplant (ITx)

B. Kosmach-Park, R. Sindhi, L. Hoffman, T. Tuite, G. Mazariegos
Partial Grafts Are Associated with an Increased Risk of Graft Failure in Liver Transplantation for Hepatocellular Carcinoma

R. Cauley, K. Potanos, N. Fullington, J. Finkelstein, D. Graham, H. Kim, K. Vakili
Pathogenesis of TIM-4 Mediated Phagocytosis in Mouse Liver Ischemia and Reperfusion Injury (IRI), The

H. Ji, Y. Zhang, Y. Liu, X. Shen, F. Gao, C. Batikian, R. Busuttil, J. Kupiec-Weglinski
Pathology and Clinical Progression of Biopsy Proven pAMR1 after Heart Transplantation

J. Patel, M. Kittleson, M. Rafiei, A. Osborne, D. Chang, L. Czer, J. Kobashigawa
Patient Survival in Renal Transplanted Patients and Hepatitis B

M. Naik, M. Duerr, K. Budde
Pattern of Utilization and Graft Outcomes of Patients Received Kidney Transplants from Deceased Donors < 4 Years, The

T. Jie, M. Porubsky, A. Rana, B. Kaplan, R. Gruessner, A. Gruessner
PCR-Based Detection for Microchimerism and Graft Outcome in Kidney Transplant Recipients

P. Carta, M. Zanazzi, P. Pinzani, F. Salvianti, D. Villari, E. Minetti
PD-1 Analysis on CD28-CD27- CD4 T-Cells Allows Rapid Stimulation-Independent Assessment of CMV-Viremic Episodes in Transplant Recipients

J. Dirks, H. Tas, T. Schmidt, S. Kirsch, B. Gärtner, U. Sester, M. Sester
Pediatric Kidneys Can Be Used To Expand the Donor Pool: An Analysis of Scientific Registry of Transplant Recipients Data

M. Suneja, S. Kuppachi, D. Katz, L. Hunsicker
Pediatric Size Matched Single Renal Transplantation

M. McMellen, J. Hopping, S. Wilson, E. Wood, E. Abraham, M. Schnitzler, J. Tuttle-Newhall
Pediatric Steroid-Free Deceased-Donor Renal Transplantation with Alemtuzamab Induction: A Seven-Year Experience

F. Darras, J. Melquist, H. DiCarlo, D. Connolly, W. Waltzer, R. Fine, K. Supe-Markovina
Pegylated Interferon Maintenance Therapy for Recurrent Hepatitis C after Liver Transplantation

C. Yazici, V. Maddukuri, G. Conner, M. Russo
Perceived Barriers to Adherence in Pediatric Transplantation from the Guardian’s Perspective

L. Danziger-Isakov, T. Frazier, S. Worley, N. Williams, N. Bridges, S. Sweet, CTOTC-05 Consortium
Perfluorocarbon Added to the University of Winsconsin Solution Reduces Ischemia Reperfusion Injury and Prolongs Survival of DCD Liver Grafts

P. Martins, T. Berendsen, H. Yeh, B. Bruinsma, M. Izamis, K. Uygun, J. McDaid, M. Yarmush, J. Markmann
Peri-Transplant Absolute Lymphocyte Count Is a Reliable Predictive Factor for Advanced Recurrence of Hepatitis C Following Liver Transplantation

S. Nagai, A. Yoshida, K. Khono, D. Altshuler, M. Nakamura, M. Kazimi, B. Kimberly, M. Abouljoud, D. Moonka
Peripheral Expression of Inflammatory Proteins and miRNAs Expression at the Time of Biopsy Proven ACR and Persistence of Immune Activation Long after Clinical Resolution

A. Shaked, J. Tobias, N. Goodrich, B. Gillespie, the A2ALL Study Group
Peripheral NK Cell Repertoire Is Modulated by Different Immunosuppressive Drugs Following Kidney Transplantation, The

C. Neudoerfl, B. Mueller, C. Blume, K. Daemen, M. Stevanovic-Meyer, J. Keil, F. Lehner, H. Haller, C. Falk
Persistent Asymptomatic C4d Staining in the First-Year after Heart Transplantation Is a Marker for Cardiac Allograft Vasculopathy

M. Rafiei, M. Kittleson, J. Patel, A. Osborne, D. Chang, L. Czer, J. Kobashigawa
Pharmaceutical Quality and Bioequivalence Assessment of Generic Mycophenolate Mofetil Tablets

W. Jiang, R. Lionberger, J. Li, Y. Peng, L. Yu
Pharmacodynamic and Immunomodulatory Effects of TOL-101: An IgM Anti-αβ TCR Monoclonal Antibody Used for Induction Therapy in Kidney Transplantation, The

A. Wiseman, S. Mulgaonkar, L. Melton, T. Waid, A. Agarwal, R. Sung, F. Shihab, D. Getts, S. Flechner
Pharmacokinetics and CYP3A5 Pharmacogenetics for Once- Versus Twice-Daily Tacrolimus from First Dosing Day to 1 Year Post-Transplantation

S. Satoh, T. Niioka, H. Kagaya, K. Numakura, M. Saito, T. Inoue, N. Komine, S. Akihama, S. Narita, N. Tsuchiya, T. Habuchi, M. Miura
Pharmacokinetics of Everolimus in Combination with Mycophenolate Sodium and Its Clinical Outcomes in Renal Trasplant Recipients Previously Treated with Calcineurin Inhibitors

C. Felipe, P. Hannun, N. Oliveira, H. Tedesco, J. Medina- Pestana
Pharmacokinetics of Voclosporin (VCS) in Renal Impairment, The

L. Aspeslet, D. Freitag, R. Huizinga, P. Mayo, S. Ling, R. Foster
Phase 3, Double-Blind, Multi-Center, Non-Inferiority, Randomized Study To Examine the Efficacy and Safety of LCP-Tacro™ Tablets, Once Daily, Compared to Prograf® Capsules, Twice Daily, in Combination with Mycophenolate Mofetil in De Novo Adult Kidney Transplantation: Baseline Characteristics, A

L. Rostaing, K. Budde, S. Bunnapradist
Phenotype and Functionality of BKV-Specific T Cells Are Differently Affected by Distinct Immunosuppressive Drugs

B. Weist, M. Schmueck, N. Babel, P. Reinke
Phenotypic Classification of Acute Rejection Correlates with Long-Term Graft Survival

J. Krisl, R. Alloway, A. Shields, A. Govil, G. Mogilishetty, M. Cardi, T. Diwan, B. Abu Jawdeh, A. Girnita, E. Woodle
Phosphatase and Tensin Homolog (PTEN) Promotes Liver Pro-Inflammatory Immune Response Against Ischemia Reperfusion Injury (IRI)

Y. Shi, J. Rao, X. Shen, F. Gao, R. Busuttil, J. Kupiec-Weglinski, Y. Zhai
Physical Activity Level Post Kidney Transplantation: Evolution and Impact on Body Composition. Results from the CORPOS Study

K. Moreau, A. Desseix, T. Bachelet, P. Merville, L. Couzi, C. Germain, R. Thiebaut, P. Chauveau
PI3Kδ Inhibition Augments the Efficacy of mTOR Inhibitor Rapamycin on the Proliferation of Epstein-Barr Virus (EBV)+ B Cell Lymphomas

S. Furukawa, O. Hatton, S. Krams, C. Esquivel, O. Martinez
Pigs Deficient in N-Glycolylneuraminic Acid and Galactose α-1,3-Galactose Reduce the Humoral Barrier to Xenotransplantation

A. Lutz, R. Sidner, P. Li, J. Estrada, L. Paris, R. Chihara, S. Downey, A. Tector
Pivotal Circulating Antibody Panel for Pre-Transplant Prediction of FSGS Recurrence after Kidney Transplantation, A

M. Sarwal, M. Delville, T. Sigdel, C. Wei, A. Fernoni, G. Burke, M. Naesens, A. Jackson, N. Alachkar, G. Canaud, C. Legendre, J. Reiser, D. Anglicheau
Plasma Osteopontin Levels Correlate with Reversible Kidney Injury in Liver Transplant Candidates

T. Baker, J. Levitsky, P. Al-Saden, D. Solomon, K. Ballard, C. Jie, M. Abecassis
Plasma Soluble IL-6 Receptor (SIL-6R) Levels Are Significantly Elevated during Antibody-Mediated Rejection (ABMR) in Highly-HLA Sensitized Renal Allograft Recipients (HS Pts)

B. Shin, J. Watanabe, S. Ge, A. Vo, S. Jordan, M. Toyoda
Platelets as Mediator of Alloantibody-Induced Responses in Vascularized Organ Transplantation

H. Kuo, R. Fan, W. Baldwin
Polyclonal Light Chain Deposition in the Proximal Tubules Early after Deceased Donor Renal Transplantation: A Contributing Factor for Graft Dysfunction?

R. Parasuraman, A. Koffron, V. Mudunuri, S. Cohn, V. Raofi, L. Rocher, M. Gabriel, S. Dilip, P. Zhang
Polymorphism of the Vitamin D Receptor and Risk of New-Onset Diabetes after Transplantation in Hispanic Kidney Transplant Recipients

D. Min, D. Vu, E. Tellez-Corrales, J. Yang, P. Sakharkar, T. Shah, I. Hutchinson
Polymorphisms in the Transcription Factor NFATc4 Gene Are Associated with BKVN in Renal Allograft Recipients

D. Vu, T. Shah, Y. Qazi, R. Naraghi, B. Kawewat, I. Hutchinson, D. Min
Polyoma BK-Virus-Specific T Cells as a Surrogate Marker for Polyomavirus-Associated Nephropathy after Pediatric Kidney Transplantation

T. Ahlenstiel, U. Sester, H. Fehrenbach, L. Pape
Polyoma Viremia Adversely Affects Renal Function at One Year in Kidney Transplant Recipients: Independent of Immunosuppressive Regimen

K. Nguyen, R. Weng, J. Foe-Parker, H. Ichii, C. Foster III
Polyomavirus Infection Augments the CD8 T Cell Response Against Antigens Expressed by Transplanted Kidneys

J. Wang, Y. Dong, C. Breeden, J. Albrecht, A. Lukacher, K. Newell
Poor Outcome in Non-Sensitized Patients Developing De Novo Circulating Antibodies after Heart Transplantation

J. Kobashigawa, M. Kittleson, M. Rafiei, A. Osborne, D. Chang, L. Czer, N. Reinsmoen, J. Patel
Population Pharmacokinetics of Tofacitinib in De Novo Kidney Transplant Patients

M. Tortorici, M. Lamba, G. Chan, S. Krishnaswami
Population Pharmacokinetics of Voclosporin: Body Surface Area Optimized Dosing

P. Mayo, S. Ling, R. Alloway
Portrait of CAD with IF-TA Development Post Kidney Transplantation. Proteomics as Noninvasive Biomarkers

R. Gehrau, D. Maluf, H. Cathro, A. King, J. Suh, K. Brayman, D. Ladie, V. Mas
Positive Flow Crossmatches in Renal Patients without “Detectable” Anti-Donor HLA Antibodies; Maximizing Renal Transplant Rate by Decreasing False Positive Crossmatches

R. Cirocco, J. Mendiolina, L. Biondi, M. Moritz
Positive Solid Phase C1q Assays in Patients with Antibody-Mediated Rejection Correlate with the Presence of HLA Antibodies with High MFI Values

T. Ellis, M. Yell, B. Muth, P. Brown, A. Djamali
Post Transplant Lymphoproliferative Disorders: Clinicopathological Analysis of 54 Cases in a Single Center

B. Kern, R. Sucher, I. Graziadei, B. Feurstein, C. Boesmueller, S. Scheidl, F. Aigner, C. Margreiter, R. Oellinger, J. Pratschke, S. Schneeberger
Post Transplant Outcomes in Elderly Renal Transplant Recipients

O. Abu-Romeh, A. Patel, O. Mariella, V. Karthikeyan, Y. Lenar, K. Venkat
Post-Transplant Colonization and Infection with Voriconazole-Resistant Mould in Lung Transplant Recipients Receiving Voriconazole Prophylaxis

J. Kim, S. Cohen, E. Allen, R. Boettger, M. Binstock, S. Arron, J. Singer, S. Hays, J. Kukreja, P. Chin-Hong
Post-Transplant Complement Binding DSA: Higher Risk of Kidney Allograft Loss

C. Lefaucheur, A. Loupy, D. Vernerey, C. Suberbielle, X. Jouven, C. Legendre, D. Glotz, A. Zeevi
Posttransplant Cardiac Event Rates Are Lower with Rapid Discontinuation of Prednisone (RDP)

A. Matas, K. Gillingham, H. Ibrahim, for the Divisions Surg and Med
Potential Contributions to the Direct Pathway by Donor Dendritic Cells at Vascularized Graft

T. Ueno, M. Yeung, K. Jun, M. McGrath, N. Da Silva, T. Ikeda, N. Najafian, B. Sylvie, D. Brown, A. Yun, R. Weissleder, M. Sayegh
Potential Downfall of Failed Prednisone Wean after Heart Transplant

J. Patel, M. Kittleson, M. Rafiei, A. Osborne, D. Chang, L. Czer, J. Kobashigawa
Potential Importance of 3 Year Surveillance Biopsies in Renal Transplantation

M. Willicombe, C. Roufosse, P. Brookes, J. Galliford, A. McLean, T. Cook, D. Taube
Practices and Attitudes toward Donor Pain Control in Adult to Adult Living Donor Liver Transplantation Cohort Study (A2ALL)

E. Pomfret, M. Simpson, D. Ladner, M. Mandell
Pre Liver Transplant Loco Regional Bridging Therapy for HCC: Efficacy of Combined TACE and RFA Versus TACE Alone Based on Explant Pathology

M. Boktour, E. Asham, C. Frenette, H. Monsour, J. Galati, K. Heyne, M. Weiner, A. Gaber, R. Ghobrial
Pre-Liver Transplant (LT) Proteinuria Is Not an Absolute Indication for Simultaneous Liver Kidney Transplantation (SLK)

H. Wadei, A. Keaveny, M. Mai, B. Rosser, M. Prendergast, K. Oshel, T. Gonwa
Pre-Recovery Liver Biopsy in Brain Death Donors – Case Control Study of Safety, Feasibility and Liver Utilization

J. Oliver, A. Bongu, B. Koneru
Pre-Transplant Cardiovascular Risk Factors Improve the SRTR Cox Proportional Hazard Model for 1 Year Patient Survival after Deceased Donor Kidney Transplant

R. Pelletier, A. Rajab, T. Pesavento, M. Henry
Pre-Transplant HLA Immunization in Kidney Transplant Recipients Is Characterized by an Activated Peripheral B Cell Phenotype and High Serum Levels of BAFF

R. Snanoudj, S. Candon, D. Roelen, F. Claas, C. Legendre, L. Chatenoud
Pre-Transplant Immediately Early-1-Specific T-Cell Responses Provides Protection for CMV Infection after Kidney Transplantation

O. Bestard, M. Lucia, E. Crespo, J. Cruzado, D. Palacio, E. Melilli, J. Torras, S. Gil-Vernet, J. Grinyó
Pre-Transplant Immunologic Risk Assessment and Immune Monitoring of Kidney Transplant Recipients with Pre-Transplant Donor-Specific Anti-HLA Antibodies

K. Marfo, M. Ajaimy, M. Lubetzky, A. Colovai, P. Masiakos, G. de Boccardo, E. Akalin
Pre-Transplant Serum IgG Reactivity to Apoptotic Cells Correlates with HLA Reactivity and Kidney Graft Loss

B. Gao, F. Porcheray, C. Moore, A. McColl, J. Ferdman, C. Abidoglu, T. Girouard, J. DeVito, R. Paine, S. Saidman, W. Wong, E. Zorn
Predicting Digest Tissue Volume of Chronic Pancreatitis Pancreas Intended for Islet Auto-Transplantation (IAT)

M. Tiwari, J. Wilhelm, M. Bellin, S. Soltani, G. Loganathan, T. Dunn, S. Chinnakotla, S. Vickers, T. Pruett, G. Beilman, D. Sutherland, B. Hering, A. Balamurugan
Predicting Graft Failure in Kidney Transplant Patients: A Combined Clinical/Molecular Approach to Analyzing Biopsies

J. Reeve, J. Sellares, D. de Freitas, G. Einecke, J. Bromberg, A. Matas, P. Halloran
Predicting Patient Survival after Kidney Transplantation (KTx): The First Year and Beyond

A. Muriithi, M. Keddis, E. Rodrigo, M. El Ters, P. Dean, H. Amer, F. Cosio
Predicting Survival and Recurrence Following Liver Transplantation for Hepatocellular Carcinoma: National Analysis of Clinical and Pathologic Staging

C. Stark, N. Dzebisashvili, G. Mezochow, A. Harper, E. Edwards, D. Axelrod, R. Freeman
Prediction of Morbidity and Mortality in Living Donor Liver Transplant and Living Donor Kidney Transplant Patients by Using Immune Function Assays

S. Mizuno, K. Nishikawa, Y. Muraki, A. Tanemura, N. Kuriyama, I. Osawa, Y. Azumi, M. Kishiwada, M. Usui, H. Sakurai, M. Tabata, Y. Sugimura, M. Okuda, S. Isaji
Predictive Value of HLA Antibody Characteristics for Progression of Subclinical Antibody Mediated Rejection in Heart Transplant Recipients

M. Askar, E. Rodriguez, P. Reville, J. Gatto, J. Schold, J. Daghstani, A. Zhang, L. Klingman, R. Starling, N. Moazami, D. Taylor, C. Tan
Predictors of Clostridium Difficile Infection in Liver Transplant Recipients: A 10 Year Single-Center Cohort Study

C. Mittal, S. Arshad, M. Miceli, I. Bajjoka, L. Brown, M. Abouljoud, M. Ramesh, G. Alangaden
Predictors of Combined Liver and Kidney Transplantation and Post-Transplant Liver Graft, Kidney Graft, and Patient Survival: Comparison to Patients Receiving Listed for Kidney but Receiving Liver Alone

A. Singal, Y. Kuo, R. Wiesner, A. Singal
Predictors of Fibrosing Cholestatic Hepatitis Development Following Liver Transplantation: Potential Impact on Donor Selection and CMV Prophylaxis

C. Yazici, C. Jacobs, W. Ahrens, P. Zamor, P. Schmeltzer, V. Casingal, L. Eskind, D. Levi, D. Hayes, M. Russo
Predictors of Poor Outcomes Following Liver Transplantation in Patients with Hepatopulmonary Syndrome

E. Cheng, R. Zopey, T. Wang, R. Busuttil
Predictors of Post-Transplant Cardiac Dysfunction in Liver Transplant Recipients

C. Mittal, S. Singla, W. Qureshi, S. Hassan, M. Huang
Predictors of Serum Uric Acid and Its Impact on Kidney Structure and Function: A Five Year Prospective Study

A. Hart, S. Jackson, A. Matas, H. Ibrahim
Preemptive Desensitization among Sensitized Renal Recipients Improves Graft Survival Despite Posttransplant DSA Persistance

P. Kimball, A. Sharma, M. Behnke, F. McDougan, A. King
Preexisting Donor Specific Antibody (DSA) with a Negative Flow Crossmatch (FCXM) Should Not Preclude Kidney Transplantation

V. Kumar, V. Hauptfeld-Dolejsek, A. Kamal Abdelkader, J. Goodman, J. Locke, R. Gaston
Preformed Anti-MICA Antibodies Negatively Impact Renal Allograft Evolution in Early Post-Transplantation Period

E. Sánchez-Zapardiel, M. Castro-Panete, M. Castillo-Rama, P. Morales, D. Lora-Pablos, D. Valero-Hervás, R. Ruiz-García, J. Apaza, P. Talayero, A. Amado, J. Morales, E. Paz-Artal
Preformed HLA Donor Specific Alloantibodies in African-Americans Increases Their Risk of Death after Liver Transplant

J. O'Leary, H. Kaneku, L. Jennings, B. Susskind, P. Terasaki, G. Klintmalm
Pregnancy Outcomes in Liver Recipients Transplanted for Biliary Atresia

C. Ramirez, C. Doria, A. Frank, W. Maley, L. Coscia, M. Moritz, V. Armenti
Pregnancy Outcomes in Solid Organ Transplant Recipients with a Switch from a Mycophenolic Acid Product to Azathioprine Prior to Conception

N. Sifontis, L. Coscia, M. Lundgren, N. Dharbhamulla, S. Constantinescu, M. Moritz, C. McGrory, C. Ramirez, V. Armenti
Pregnancy Outcomes in Solid Organ Transplant Recipients with Exposure to Sirolimus

S. Constantinescu, L. Coscia, M. Moritz, C. McGrory, C. Ramirez, V. Armenti
Preliminary Experience Utilizing Boceprevir with Pegylated Interferon and Ribavirin for Treatment of Recurrent Hepatitis C Genotype 1 after Liver Transplantation

B. Aqel, E. Carey, D. Douglas, T. Byrne, J. Rakela, W. Susan, H. Vargas
Preliminary Psychometric Properties of a Measure of the Allocation of Responsibility for Health Management Tasks in Pediatric Liver Transplant Recipients

J. Bilhartz, M. Lopez, J. Magee, V. Shieck, S. Eder, R. Gleit, E. Fredericks
Preoperative Amino Acid Free Diet Protects Against Hepatic Ischemia Reperfusion Injury, A

T. Saat, T. van Ginhoven, M. Verweij, L. van der Laan, J. IJzermans, R. de Bruin
Preoperative Fasting Protects Aged Obese Mice Against Renal Ischemia-Reperfusion Injury

F. Jongbloed, R. de Bruin, S. van den Engel, L. van der Laan, H. van Steeg, J. IJzermans, M. Dollé
Presence of Circulating Antibodies at the Time of Pathology Defined Antibody-Mediated Rejection after Heart Transplant: Are They out There?, The

J. Patel, M. Kittleson, M. Rafiei, A. Osborne, D. Chang, L. Czer, N. Reinsmoen, J. Kobashigawa
Presence of Polyomavirus BK Replication in Urine or Plasma Correlate with Significant Renal Impairment in Renal Transplant Recipients, The

M. Eng, C. Jones, M. Hughes, E. Davis, M. Marvin
Presence of Pre-Transplant Donor Specific Antibody (DSA) Does Not Reduce Pancreas Allograft Survival in Recipients Treated with IVIG

M. Boehnert, M. Selzner, M. Marquez, F. Bazerbachi, A. Norgate, I. McGilvray, J. Schiff, M. Cattral
Presence of Preformed IgG3 DSA Identifies Patients at Higher Risk of Early Rejection in Liver Transplantation

H. Kaneku, J. O'Leary, N. Bañuelos, L. Jennings, B. Susskind, G. Klintmalm, P. Terasaki
Preservation of CMV-Specific Memory T Cell Responses with Belatacept

H. Xu, A. Mehta, J. Cheeseman, T. Pearson, C. Larsen, A. Kirk
Pretransplant CD8+CD28-NKG2D+ Memory T Cells and Third Party Cellular Alloreactivity as a Predictor of Posttransplant Acute Cellular Rejection

O. Traitanon, J. Augustine, R. Fairchild, E. Poggio
Pretransplant Donor-Specific HLA-Cw Antibodies and Risk of Antibody-Mediated Rejection

M. Bories, O. Aubert, C. Suberbielle, A. Loupy, F. Martinez, D. Anglicheau, R. Snanoudj, M. Timsit, D. Charron, C. Legendre, R. Sberro Soussan
Pretransplant FGF23 Titer Predicts Hypercalcemia at 6month Post Transplant Recipients

M. Tsujita, T. Yamamoto, T. Hiramitsu, K. Nanmoku, N. Goto, D. Inaguma, Y. Watarai, Y. Tominaga
Pretransplant Infusion of Donor Stem Cells Open Gateway to Tolerance through Induction of Regulatory T Cells and Activation of Other Allosuppressive Immune Mechanisms – Single Centre Experience in Living Donor Renal Transplantation

H. Trivedi, A. Vanikar, V. Kute, H. Patel, M. Gumber, P. Shah, S. Dave, V. Trivedi
Pretransplant Malnutrition and Inflammation Affects the Outcome after Kidney Transplantation, The

J. Hwang, S. Yang, J. Yang, J. Ha, Y. Oh, C. Lim, J. Lee, Y. Kim
Prevalence and Outcomes of Pulmonary Embolism in Patients with Kidney Transplant

A. Sakhuja, J. Schold, D. Deitzer, B. Stephany
Prevalence and Predictive Factors of Early Cardiovascular Events after Kidney Transplantation: Which Screening Strategy?

M. Delville, L. Sabbah, D. Girard, C. Elié, F. Martinez, A. Méjean, C. Legendre, R. Sberro-Soussan
Prevalence of Human Papillomavirus (HPV) Infection in Female Kidney Transplant Recipients

J. Mayorga, M. Jiménez-Santana, R. Barrón, R. Gamboa-Martínez, J. Sifuentes-Osornio, M. Cravioto, J. Alberu
Prevalence of Metabolic Syndrome in Renal Transplant Patients: Comparison of Two Diagnostic Criteria

F. Agena, E. Prado, F. Lemos, W. Nahas, E. David-Neto
Prevalence of Venous Thromboembolism Post-Kidney Transplant: A Single Center Experience

K. Nenno, W. Ally, S. Palkimas, M. Campolieto, B. Macik, K. Brayman, A. Agarwal
Prevascularized Tissue-Engineered Construct Serves as an Alternative Site for Pancreatic Islet Transplantation, A

G. Zhao, M. Yang, L. Wei, X. Huang, J. Lei, J. Markmann, S. Deng
Prevention of Cytomegalovirus with Valganciclovir 450mg Daily vs. 900mg Daily in Intermediate Risk Renal Transplant Recipients (D-/R+); a Multicenter Safety and Efficacy Evaluation

S. Gabardi, R. Cross, K. DePiero, T. Dick, K. Ferguson, E. Newkirk, J. Park, E. Tichy, K. Ueda, R. Weng, S. Heldenbrand
Prevention of Early Graft Loss by Proliferator-Activated Receptor-γ Agonist, Pioglitazonoe, in Canine Islet Autotransplantation

Y. Asahi, K. Yamashita, M. Watanabe, M. Ogura, H. Ono, E. Handly, S. Emoto, A. Nagatsu, T. Yoshida, Y. Koshizuka, H. Kamachi, A. Taketomi, S. Todo
Prevention of Poor Psychosocial Outcomes in Living Kidney and Liver Donors: Feasibility and Efficacy in a Randomized Controlled Trial

M. Dew, A. DiMartini, A. DeVito Dabbs, A. Zuckoff, H. Tan, M. McNulty, G. Switzer, K. Fox, J. Greenhouse, A. Humar
Primary Cytomegalovirus Infection Has a Limited Effect on the Immunological Age of Kidney Transplant Recipients

R. Meijers, N. Litjens, E. de Wit, A. Langerak, C. Baan, W. Weimar, M. Betjes
Primary Graft Dysfunction vs. Primary Graft Failure: Are All Graft Problems Created Equal?

A. Aliabadi, M. Groemmer, D. Wiedemann, D. Zimpfer, G. Laufer, A. Zuckermann
Prior Simultaneous Pancreas-Kidney Transplant (SPK) Recipients with a Functioning Pancreas Allograft Have Improved Patient and Graft Survival after Kidney Retransplantation

Z. Stewart, L. Hunsicker
Prioritization Due to Dialysis Access Failure Impacts on Patient Survival after Kidney Transplantation

J. Reusing Jr., P. Souza, N. Galante, F. Agena, F. de Paula, W. Nahas, E. David-Neto
Priority Pass to Death – Prioritization of Liver Transplant for HCC Worsens Survival, A

K. Halazun, E. Verna, B. Samseitn, J. Guarrera, T. Kato, R. Brown Jr, J. Emond
Probability of a Positive AHG-CDC Crossmatch Is Determined by the Number, Strength, and Specificity of Donor-Specific Antibodies

J. Lan, G. Espino-Hernandez, J. Gill, P. Keown
Probability of Deceased Donor Kidney Transplantation Based on PRA%

I. Bostock, J. Alberu, A. Adriana, D. Adrian, G. Norma, L. Mayra, C. Natalia, M. Luis, G. Bernardo, V. Mario
Problems and Pitfalls in Calculation of “True” Treg Numbers Using Assays of Foxp3 TSDR Demethylation in PBMC of Transplant Recipients

T. Akimova, B. Kamath, J. Goebel, K. Meyers, E. Rand, M. Levine, J. Bucuvalas, W. Hancock
Product of Donor Age and Preoperative MELD, D−MELD, Predicts Surgical Outcomes after LDLT in HCV Positive Recipients, but Not in HCV Negative Recipients, The

A. Tanemura, S. Mizuno, N. Kuriyama, Y. Azumi, I. Osawa, M. Kishiwada, M. Usui, H. Sakurai, M. Tabata, S. Isaji
Prognostic Significance of Changes in Proteinuria in Early Stages of Renal Transplantation

A. Sancho Calabuig, E. Gavela Martínez, J. Kanter Berga, B. Vizcaíno, S. Beltrán, L. Pallardó Mateu
Prognostic Utility of Hypothermic Machine Perfusion Correlates with the Kidney Donor Risk Index (KDRI) in Kidney Transplantation, The

S. Patel, O. Pankewycz, B. Mahmood, M. Zachariah, M. Said, L. Feng, A. Desai, J. Brar, M. Laftavi
Prognostic Utility of Hypothermic Machine Perfusion Parameters: Do They Improve Predictive Value of KDRI in Deceased Donor Kidney Transplantation?

A. Nishio, J. Ma, D. Keith
Prognostic Value of SRTR Kidney Transplant Report Cards in the United States, The

E. Heaphy, D. Goldfarb, A. Sehgal, J. Fung, M. Kattan, L. Buccini, J. Schold
Progression of Pathologic Changes in Kidney Allografts of HLA-Incompatible Transplant Recipients

S. Bagnasco, A. Zachary, L. Racusen, L. Arend, R. Montgomery, E. Kraus
Project NOTIFY: A Global Database of Serious Adverse Events and Reactions in Organs, Tissues, and Cells

M. Ison, D. Strong, D. Fehily, E. Chatzixiros, A. Costa, L. Noel
Prolonged Cardiac Allograft Survival Due to Treg Expansion in Recipient BAFF-Tg Mice

M. Saito, G. Zhang, Y. Wang, M. Hu, S. Walters, J. Zhou, A. Sawyer, J. Chapman, S. Grey, S. Alexander
Prolonged Cold Ischemia Impairs Outcome in Recipients of DCD Kidney Transplants, Despite Machine Perfusion

S. Paloyo, J. Sageshima, G. Ciancio, L. Chen, A. Mattiazzi, G. Guerra, W. Kupin, D. Roth, S. Ganz, G. Burke III
Prolonged Cold Ischemia Impairs Outcome in Recipients of Donation after Cardiac Death (DCD) Kidney Transplants Despite Machine Perfusion

S. Paloyo, J. Sageshima, G. Ciancio, L. Chen, A. Mattiazzi, G. Guerra, W. Kupin, D. Roth, S. Ganz, G. Burke III
Prolonged Cold Ischemia Increases the Early Infiltration and Effector Functions of Memory CD8 T Lymphocytes in Cardiac Allografts

C. Su, S. Iida, T. Abe, R. Fairchild
Prolonged Delayed Graft Function Is Associated with Inferior Patient and Kidney Allograft Survivals

T. Sandes-Freitas, R. Klein, H. Tedesco, J. Medina- Pestana
Prolonged Extraction Time of Kidneys from Deceased Donors Impacts Function

A. Osband, N. James, C. Keating, D. Segev
Promising Outcomes after Long-Term Therapy with Everolimus in Kidney Transplant Patients: Two-Years Results of the CERTIC Registry

M. Carmellini, S. Federico, P. Messa, G. Gubbiotti, M. Salvadori, D. Colombo, R. Brusa, C. Ponticelli
Pronounced Impact of Community Risk Factors on Pre-Transplant Kidney Candidate Processes and Outcomes

E. Heaphy, L. Buccini, T. Srinivas, E. Poggio, D. Goldfarb, S. Flechner, J. Rodrigue, D. Thornton, A. Sehgal, J. Schold
Proposed Surveillance Strategy for Hepatocellular Carcinoma Recurrence after Liver Transplantation, A

D. Levi, M. Russo, K. Uchida, S. Nishida, A. Tzakis
Prospective Analysis of CD19dimCD27highCD20neg Blood Plasma Cells in Renal Transplant Patients after Combined Treatment with Rituximab and Bortezomib in Antibody Mediated Rejection

M. Duerr, L. Deutsch, L. Anwari, H. Mei, H. Neumayer, K. Budde
Prospective and Randomized Trial Comparing Tacrolimus Versus Sirolimus after Simultaneous Pancreas-Kidney Transplantation

D. Cantarovich, E. Papuchon, G. Blancho, J. Dantal, M. Giral, J. Branchereau, G. Karam
Prospective Comparative Study of a Strategy of Systematic Search and Treatment Versus No Treatment of Asymptomatic Bacteriuria (AB) in Kidney Transplant (KT) Recipients: Preliminary Results

J. Origüen, F. López-Medrano, M. Pérez-Jacoiste, A. García-Reyne, M. Fernández-Ruiz, N. Carrasco, T. Silva, J. Morales, A. Andrés, J. Aguado
Prospective Randomized Study of Low Dose Antithymocyte Globulin as Induction in Non Sensitized Adult Renal Transplant Recipients

M. Grafals, M. Simpson, H. Gilligan, J. Pomposelli, M. Akoad, K. Kwaja, A. Trabucco, K. Hamill, E. Pomfret
Prospective Randomized Trial Aimed To Reduce the Incidence of Cytomegalovirus (CMV) Infection in Kidney Transplant (KT) Recipients, A

H. Tedesco, C. Felipe, L. Wang, C. Rodrigues, T. Sandes, M. Cristelli, M. Franco, J. Medina-Pestana
Prospective Surveillance of Kidney Transplant Recipients for BK Viremia Can Reduce or Eliminate BK Virus Associated Nephropathy (BKVAN) Related Graft Loss: Results of a 5-Year Screening Study

N. Elfadawy, S. Flechner, X. Liu, J. Schold, R. Fatica, T. Srinivas, E. Poggio, R. Avery, S. Mossad
Prospective, Iterative, Phased, Trial of Proteasome Inhibitor-Based Desensitization in Highly Sensitized Renal Transplant Candidates, A

E. Woodle, B. Sadaka, R. Walsh, A. Shields, A. Girnita, P. Brailey, R. Alloway, M. Cardi, A. Govil, B. Abu Jawdeh, P. Roy Chaudhury, G. Mogilishetty
Prospective, Randomized Pilot Study of B-Cell Targeted Induction Therapy in Sensitized Kidney Transplant Recipients: Final Report, A

N. Ejaz, A. Shields, R. Alloway, B. Sadaka, A. Girnita, G. Mogilishetty, J. Kremer, M. Cardi, E. Woodle
Proteasome Inhibition Protects Steatotic Liver Graft through Modulation of the AMPK, Akt and mTOR Pathways

M. Bejaoui, M. Zaouali, T. Carbonell, F. Bardag-Gorce, E. Pantazi, H. Abdennebi, J. Roselló-Catafau
Proteasome Inhibitor-Related Toxicities in a Prospective Trial of Desensitization

N. Ejaz, R. Alloway, B. Sadaka, A. Shields, B. Abu Jawdeh, F. Paterno, M. Cardi, E. Woodle
PROTECT Study: 35 Months of Everolimus Monotherapy vs. Calcineurin Inhibitor-Based Therapy Showed To Be a Safe Alternative with Superior Renal Function in Liver Transplant Recipients, The

H. Schlitt, G. Kaiser, N. Richter, N. Heyne, F. Rauchfuss, P. Neuhaus, P. Schemmer, L. Fischer, E. Paulus, M. Mertens, M. Sterneck
Protection from Prolonged Cold Ischemia (CI) of Several Days Duration Is Mediated by Anti-Apoptotic phosphoBAD during Hibernation

A. Jani, S. Jain, T. Nydam, C. Edelstein
Protective Effect and Mechanism of NKA DR Region Specific Antibody on Ischemia-Reperfusion-Induced Renal Injury in Rats

J. Zheng, W. Xue, P. Tian, X. Ding, H. Yan, J. Hou, X. Tian, Y. Li, C. Ding
Protective Effect of a FDA-Approved Intralipid on Kidney Ischemia/Reperfusion Injury

Q. Ye, L. Liu, Y. Wu, T. Hitchens, F. Yhe, B. Barbe, W. Li, C. Ho
Protective Effect of Carbon Monoxide-Releasing Molecules in Renal Ischemia-Reperfusion Injury Is Associated with Profound Inhibition of HMGB1 Cytoplasmic Translocation, The

G. Chen, Y. Ruan, L. Wang, Y. Xiang, H. Guo, Y. Zhao
Protective Effect of Non-HLA IgG2 and Detrimental Effect of Non-HLA IgG1 & IgG3 Against Angiotensin II Type 1 Receptor (AT1R) in Kidney Transplantation

M. Taniguchi, L. Rebellato, J. Cai, H. Heidecke, K. Schulze-Forster, D. Dragun, J. Hopfield, K. Briley, C. Haisch, P. Bolin, K. Parker, W. Kendrick, S. Kendrick, R. Harland, P. Terasaki
Protective Effect of Nrf2-keap1 Pathway on Islet Cells Using Islet Isolation Model

S. Li, Y. Masuda, M. Hajighasemi-Ossareh, A. Le, J. Chan, C. Foster, N. Vaziri, H. Ichii
Protects Effect of HIF-1α in Ischemia/Reperfusion-Induced Mitochondrial Injury, The

Y. Guo, L. Feng, Y. Zhou, M. Xia, G. Sun, S. Li, D. Long, Y. Li
Proteinkinase C Alpha Contributes to Impairment of Renal Blood Flow and Inflammation in Hypoxia Induced Renal Ischemia Reperfusion Injury (IRI)

D. Walacides, N. Rüskamp, R. Song, K. Hueper, M. Mengel, M. Meier, H. Haller, M. Schiffer, F. Gueler
Proteinkinase C Epsilon Contributes to Impairment of Renal Blood Flow and Inflammation in Renal Ischemia Reperfusion Injury (IRI)

N. Rüskamp, D. Walacides, R. Song, K. Hüper, M. Mengel, M. Meier, D. Wacker, M. Schiffer, H. Haller, F. Gueler
Protocol Biopsies Are Valuable in High Immunologic Risk Patients

S. Patel, S. Mohan, R. Crew, Z. Zaky, D. Tsapepas, L. Ratner
Protocol Biopsies in ABO-Incompatible Versus ABO-Compatible Living Donor Kidney Transplant Recipients

A. Sanchez-Escuredo, F. Diekmann, I. Revuelta, M. Solé, J. Cid, M. Lozano, M. Blasco, J. Campistol, F. Oppenheimer
Proton Beam Radiotherapy (PBRT) Versus Tace for Hepatocellular Carcinoma (HCC) Prior to Liver Transplantation (LT)

M. de Vera, A. Elihu, J. Clark, J. Smith, B. Elhazin, R. Kumari, V. Stead, D. Scavone, V. Sundaram, T. Amankonah, P. Baron, D. Bush
Psychiatric Outcomes of Liver Transplantation after Acetaminophen Overdose

T. Dolenc, J. Bostwick, S. Jowsey, T. Schneekloth, T. Rummans
Psychosocial Outcomes 3 to 9 Years after Living Liver Donation in the Adult to Adult Living Donor Liver Transplantation Cohort Study (A2ALL)

M. Dew, Z. Butt, A. DiMartini, D. Ladner, M. Simpson
PTC Taste Status and TAS2R38 Genotype as a Possible Indicator for Alcohol Use in Liver Transplant Patients

A. David, E. Langnas, C. Teperman, B. Gelb, G. Morgan, L. Teperman
Public Awareness and Attitudes to Living Organ Donation

A. Tong, J. Chapman, G. Wong, M. Josephson, J. Craig
Public Survey of Acceptable Financial Incentives for Living Donation: Challenging Assumptions and Reinvigorating the Debate, A

C. Patel, M. Sohn, B. Hippen, L. Sherman, E. Gordon
Pulmonary Hypertension Identified by Color Doppler Echocardiography in Renal Transplant Candidates: Prevalence and Effect on Survival

A. Ribeiro, M. Gazzana, A. Vicari, M. Knorst, R. Manfro
Pulmonary Vascular Hemodynamics Improvement with Left Ventricular Assist Devices Unloading Is Sustained after Heart Transplantation

A. Saidi, O. Wever-Pinzon, J. Stehlik, E. Gilbert, R. Alharethi, C. Selzman, B. Reid, D. Budge, A. Kfoury, F. Bader
Pus Bonum Et Laudabile? – Wound Healing Complications after Heart Transplantation in the 21st Century

M. Groemmer, A. Aliabadi, O. Salameh, M. Kohl, D. Wiedemann, O. Paljakka, G. Laufer, A. Zuckermann